Back to Results
First PageMeta Content
Biology / Herpesviruses / Chickenpox / Varicella zoster virus / Herpes zoster / Zoster-immune globulin / Vaccine / Herpes simplex / Vaccination / Medicine / Microbiology / Viral diseases


Massachusetts Department of Public Health Division of Epidemiology and Immunization VariZIG™ Investigational New Drug Available for Postexposure Prophylaxis of Varicella June 2006
Add to Reading List

Document Date: 2013-08-30 23:01:16

Open Document

File Size: 158,85 KB

Share Result on Facebook

Company

Cangene Corporation / FFF Enterprises / /

Country

United States / /

/

IndustryTerm

expanded access protocol / treatment site / monitor for sign and symptoms / /

MedicalCondition

varicella disease / disease / acute illness / chickenpox / herpes zoster / mild atypical varicella / typical varicella case / diseases / varicella zoster immune globulin / varicella virus / prior infection / past disease / illness / severe disease / varicella / typical disease / /

MedicalTreatment

vaccination / Bone marrow transplant / /

Organization

Advisory Committee on Immunization Practices / Administration of VariZIG™ / Massachusetts Department of Public Health Division of Epidemiology and Immunization VariZIG™ Investigational New Drug Available for Postexposure Prophylaxis / FDA / If administration / Public Health Division of Epidemiology and Immunization VariZIG™ Investigational New Drug Available for Postexposure Prophylaxis of Varicella / /

/

Position

investigator / physician / /

Product

acyclovir / /

ProvinceOrState

Indiana / /

Technology

expanded access protocol / /

URL

http /

SocialTag